News

‘Human-on-a-Chip’ Disease Model Can Potentially Test Therapies Better

“Human-on-a-chip” technology developed by Hesperos can be used to model myasthenia gravis (MG), a new study shows. “This system has the potential to help researchers understand which mechanisms are driving a specific patient’s disease, including presence of particular autoantibodies [self-targeting antibodies], and could be used to further evaluate…

Woman Diagnosed Postpartum With MG, Autoimmune Liver Disease

A 31-year-old woman was diagnosed with two autoimmune conditions — myasthenia gravis (MG) and a liver disease called primary biliary cirrhosis — after giving birth, a recent case study reported. “Given the fluctuation of the immune status during the postpartum period, combined autoimmune diseases need to be taken into…

Rare Case of MG and Bone Marrow Disorders Reported

An extremely rare case of myasthenia gravis (MG) associated with paroxysmal nocturnal hemoglobinuria (PNH) and aplastic anemia (AA), two bone marrow failure conditions in which the immune system mistakenly attacks developing red blood cells, was reported recently. The report, “Myasthenia gravis and paroxysmal nocturnal hemoglobinuria after thymectomy: A…

Older Age, Blood Analysis Aid in Predicting Myasthenic Crisis Severity

Older age, moderate‐to‐severe anemia, and extremely high white blood cell counts were significant predictors of in‐hospital mortality in myasthenia gravis (MG) patients having a myasthenic crisis — marked by severe difficulties in breathing that require mechanical ventilation — a study from Taiwan reported. The study, “Hemogram parameters can…

2021 Myasthenia Gravis Survey Results

BioNews Survey Infographic

Myasthenia Gravis News conducted a survey from Feb. 11-March 28 to gain greater insight into the characteristics of the MG community and disease management. Results of the survey have now been published. Click on the image to view the infographic, and click here to read the story.